Skip to main content
. 2022 Sep 21;10(10):2353. doi: 10.3390/biomedicines10102353

Table 3.

Other clinical indications for HFNC in pediatric patients.

Disease Reference Study Design Study Population Comparison Main Results
Congenital heart diseases Shioji et al. [26] Retrospective study 35 children with congenital heart disease surgically corrected and acute respiratory failure HFNC and NIV
  1. Lower intubation rate in the HFNC group

  2. Shorter PICU stay in the HFNC group

OSAS McGinley et al. [27] Retrospective study 12 children with a mean age of 10 years with mild-to-severe OSAS HFNC vs. CPAP Similar reductions in AHI in both groups
Ignatiuk et al. [28] Retrospective study
22 children with poor surgical candidacy or residual OSAS after surgery HFNC vs. no intervention Significant reduction in AHI with HFNC
Hawkins et al. [29] Observational study 10 school-aged patients with OSAS treated with HFNC HFNC vs. no intervention
  1. Lower median obstructive AHI

  2. Decreased oxygen desaturation index

  3. Reduced heart rate

Pneumonia Liu et al. [33] RCT 84 children < 2 years with pneumonia and mild to moderate respiratory failure HFNC and CPAP
  1. Similar intubation rate and PICU transfer

  2. No significant difference between the two groups in the length of hospital stay

  3. Lower adverse events rate (such as abdominal distension, trauma of the nasal mucosa) in the HFNC group

AHI, apnea-hypopnea index; COT, conventional oxygen therapy; CPAP, continuous positive airway pressure; HFNC, high-flow nasal cannula; NIV, noninvasive ventilation; PICU, pediatric intensive care unit; OSAS, obstructive sleep apnea.